Another pathway to control type II diabetes is through the inhibition of DPP-IV, the enzyme that degrades incretin hormones including GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.